Natalizumab treatment reduces L-selectin (CD62L) in CD4+ T cells. Spadaro M, Caldano M, Marnetto F, Lugaresi A, Bertolotto A J Neuroinflammation. 2015; 12:146. Epub 2015 Aug 12. PMID: 26259673. Abstract CommentRecommendBookmarkWatch